High‑throughput workflows to assess functional potency of engineered immune cells

This white paper presents a streamlined workflow for characterizing the functional potency of engineered immune cells used in cell therapy. By combining broad multiplex analysis with highly sensitive targeted immunoassays, users can evaluate key cytokines, chemokines, and effector molecules that define immune cell activity. The approach supports deeper insight into mechanism of action, donor‑to‑donor variability, and overall therapeutic relevance while reducing hands‑on time and improving reproducibility. This enables researchers and developers to move efficiently from exploratory profiling to focused multi‑analyte potency assays that better reflect true biological function and support robust quality assessment across diverse cell therapy programs.